Report cover image

Global Image-based FFR Diagnosis Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 06, 2026
Length 196 Pages
SKU # APRC20776279

Description

The global Image-based FFR Diagnosis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Image-based FFR Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Image-based FFR Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Image-based FFR Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Image-based FFR Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Image-based FFR Diagnosis include HeartFlow, Medis QFR, Beijing Heart Century, Raysight, Keya Medical, ArteryFlow Technology, Pulse Medical Imaging, Fosun Aitrox and Beijing GuanShengYun, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Image-based FFR Diagnosis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Image-based FFR Diagnosis, also provides the revenue of main regions and countries. Of the upcoming market potential for Image-based FFR Diagnosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Image-based FFR Diagnosis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Image-based FFR Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Image-based FFR Diagnosis revenue, projected growth trends, production technology, application and end-user industry.


Image-based FFR Diagnosis Segment by Company

HeartFlow
Medis QFR
Beijing Heart Century
Raysight
Keya Medical
ArteryFlow Technology
Pulse Medical Imaging
Fosun Aitrox
Beijing GuanShengYun
Shukun
ShengShi

Image-based FFR Diagnosis Segment by Type

CT-FFR
QFR
Others

Image-based FFR Diagnosis Segment by Application

Hospital
Imaging Center

Image-based FFR Diagnosis Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Image-based FFR Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Image-based FFR Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Image-based FFR Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Image-based FFR Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Image-based FFR Diagnosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Image-based FFR Diagnosis revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Image-based FFR Diagnosis Market by Type
1.2.1 Global Image-based FFR Diagnosis Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 CT-FFR
1.2.3 QFR
1.2.4 Others
1.3 Image-based FFR Diagnosis Market by Application
1.3.1 Global Image-based FFR Diagnosis Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Hospital
1.3.3 Imaging Center
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Image-based FFR Diagnosis Market Dynamics
2.1 Image-based FFR Diagnosis Industry Trends
2.2 Image-based FFR Diagnosis Industry Drivers
2.3 Image-based FFR Diagnosis Industry Opportunities and Challenges
2.4 Image-based FFR Diagnosis Industry Restraints
3 Global Growth Perspective
3.1 Global Image-based FFR Diagnosis Market Perspective (2021-2032)
3.2 Global Image-based FFR Diagnosis Growth Trends by Region
3.2.1 Global Image-based FFR Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Image-based FFR Diagnosis Market Size by Region (2021-2026)
3.2.3 Global Image-based FFR Diagnosis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Image-based FFR Diagnosis Revenue by Players
4.1.1 Global Image-based FFR Diagnosis Revenue by Players (2021-2026)
4.1.2 Global Image-based FFR Diagnosis Revenue Market Share by Players (2021-2026)
4.1.3 Global Image-based FFR Diagnosis Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Image-based FFR Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Image-based FFR Diagnosis Key Players Headquarters & Area Served
4.4 Global Image-based FFR Diagnosis Players, Product Type & Application
4.5 Global Image-based FFR Diagnosis Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Image-based FFR Diagnosis Market CR5 and HHI
4.6.3 2025 Image-based FFR Diagnosis Tier 1, Tier 2, and Tier 3
5 Image-based FFR Diagnosis Market Size by Type
5.1 Global Image-based FFR Diagnosis Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Image-based FFR Diagnosis Revenue by Type (2021-2032)
5.3 Global Image-based FFR Diagnosis Revenue Market Share by Type (2021-2032)
6 Image-based FFR Diagnosis Market Size by Application
6.1 Global Image-based FFR Diagnosis Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Image-based FFR Diagnosis Revenue by Application (2021-2032)
6.3 Global Image-based FFR Diagnosis Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 HeartFlow
7.1.1 HeartFlow Company Information
7.1.2 HeartFlow Business Overview
7.1.3 HeartFlow Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.1.4 HeartFlow Image-based FFR Diagnosis Product Portfolio
7.1.5 HeartFlow Recent Developments
7.2 Medis QFR
7.2.1 Medis QFR Company Information
7.2.2 Medis QFR Business Overview
7.2.3 Medis QFR Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.2.4 Medis QFR Image-based FFR Diagnosis Product Portfolio
7.2.5 Medis QFR Recent Developments
7.3 Beijing Heart Century
7.3.1 Beijing Heart Century Company Information
7.3.2 Beijing Heart Century Business Overview
7.3.3 Beijing Heart Century Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.3.4 Beijing Heart Century Image-based FFR Diagnosis Product Portfolio
7.3.5 Beijing Heart Century Recent Developments
7.4 Raysight
7.4.1 Raysight Company Information
7.4.2 Raysight Business Overview
7.4.3 Raysight Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.4.4 Raysight Image-based FFR Diagnosis Product Portfolio
7.4.5 Raysight Recent Developments
7.5 Keya Medical
7.5.1 Keya Medical Company Information
7.5.2 Keya Medical Business Overview
7.5.3 Keya Medical Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.5.4 Keya Medical Image-based FFR Diagnosis Product Portfolio
7.5.5 Keya Medical Recent Developments
7.6 ArteryFlow Technology
7.6.1 ArteryFlow Technology Company Information
7.6.2 ArteryFlow Technology Business Overview
7.6.3 ArteryFlow Technology Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.6.4 ArteryFlow Technology Image-based FFR Diagnosis Product Portfolio
7.6.5 ArteryFlow Technology Recent Developments
7.7 Pulse Medical Imaging
7.7.1 Pulse Medical Imaging Company Information
7.7.2 Pulse Medical Imaging Business Overview
7.7.3 Pulse Medical Imaging Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.7.4 Pulse Medical Imaging Image-based FFR Diagnosis Product Portfolio
7.7.5 Pulse Medical Imaging Recent Developments
7.8 Fosun Aitrox
7.8.1 Fosun Aitrox Company Information
7.8.2 Fosun Aitrox Business Overview
7.8.3 Fosun Aitrox Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.8.4 Fosun Aitrox Image-based FFR Diagnosis Product Portfolio
7.8.5 Fosun Aitrox Recent Developments
7.9 Beijing GuanShengYun
7.9.1 Beijing GuanShengYun Company Information
7.9.2 Beijing GuanShengYun Business Overview
7.9.3 Beijing GuanShengYun Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.9.4 Beijing GuanShengYun Image-based FFR Diagnosis Product Portfolio
7.9.5 Beijing GuanShengYun Recent Developments
7.10 Shukun
7.10.1 Shukun Company Information
7.10.2 Shukun Business Overview
7.10.3 Shukun Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.10.4 Shukun Image-based FFR Diagnosis Product Portfolio
7.10.5 Shukun Recent Developments
7.11 ShengShi
7.11.1 ShengShi Company Information
7.11.2 ShengShi Business Overview
7.11.3 ShengShi Image-based FFR Diagnosis Revenue and Gross Margin (2021-2026)
7.11.4 ShengShi Image-based FFR Diagnosis Product Portfolio
7.11.5 ShengShi Recent Developments
8 North America
8.1 North America Image-based FFR Diagnosis Revenue (2021-2032)
8.2 North America Image-based FFR Diagnosis Revenue by Type (2021-2032)
8.2.1 North America Image-based FFR Diagnosis Revenue by Type (2021-2026)
8.2.2 North America Image-based FFR Diagnosis Revenue by Type (2027-2032)
8.3 North America Image-based FFR Diagnosis Revenue Share by Type (2021-2032)
8.4 North America Image-based FFR Diagnosis Revenue by Application (2021-2032)
8.4.1 North America Image-based FFR Diagnosis Revenue by Application (2021-2026)
8.4.2 North America Image-based FFR Diagnosis Revenue by Application (2027-2032)
8.5 North America Image-based FFR Diagnosis Revenue Share by Application (2021-2032)
8.6 North America Image-based FFR Diagnosis Revenue by Country
8.6.1 North America Image-based FFR Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Image-based FFR Diagnosis Revenue by Country (2021-2026)
8.6.3 North America Image-based FFR Diagnosis Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Image-based FFR Diagnosis Revenue (2021-2032)
9.2 Europe Image-based FFR Diagnosis Revenue by Type (2021-2032)
9.2.1 Europe Image-based FFR Diagnosis Revenue by Type (2021-2026)
9.2.2 Europe Image-based FFR Diagnosis Revenue by Type (2027-2032)
9.3 Europe Image-based FFR Diagnosis Revenue Share by Type (2021-2032)
9.4 Europe Image-based FFR Diagnosis Revenue by Application (2021-2032)
9.4.1 Europe Image-based FFR Diagnosis Revenue by Application (2021-2026)
9.4.2 Europe Image-based FFR Diagnosis Revenue by Application (2027-2032)
9.5 Europe Image-based FFR Diagnosis Revenue Share by Application (2021-2032)
9.6 Europe Image-based FFR Diagnosis Revenue by Country
9.6.1 Europe Image-based FFR Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Image-based FFR Diagnosis Revenue by Country (2021-2026)
9.6.3 Europe Image-based FFR Diagnosis Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Image-based FFR Diagnosis Revenue (2021-2032)
10.2 China Image-based FFR Diagnosis Revenue by Type (2021-2032)
10.2.1 China Image-based FFR Diagnosis Revenue by Type (2021-2026)
10.2.2 China Image-based FFR Diagnosis Revenue by Type (2027-2032)
10.3 China Image-based FFR Diagnosis Revenue Share by Type (2021-2032)
10.4 China Image-based FFR Diagnosis Revenue by Application (2021-2032)
10.4.1 China Image-based FFR Diagnosis Revenue by Application (2021-2026)
10.4.2 China Image-based FFR Diagnosis Revenue by Application (2027-2032)
10.5 China Image-based FFR Diagnosis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Image-based FFR Diagnosis Revenue (2021-2032)
11.2 Asia Image-based FFR Diagnosis Revenue by Type (2021-2032)
11.2.1 Asia Image-based FFR Diagnosis Revenue by Type (2021-2026)
11.2.2 Asia Image-based FFR Diagnosis Revenue by Type (2027-2032)
11.3 Asia Image-based FFR Diagnosis Revenue Share by Type (2021-2032)
11.4 Asia Image-based FFR Diagnosis Revenue by Application (2021-2032)
11.4.1 Asia Image-based FFR Diagnosis Revenue by Application (2021-2026)
11.4.2 Asia Image-based FFR Diagnosis Revenue by Application (2027-2032)
11.5 Asia Image-based FFR Diagnosis Revenue Share by Application (2021-2032)
11.6 Asia Image-based FFR Diagnosis Revenue by Country
11.6.1 Asia Image-based FFR Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Image-based FFR Diagnosis Revenue by Country (2021-2026)
11.6.3 Asia Image-based FFR Diagnosis Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Image-based FFR Diagnosis Revenue (2021-2032)
12.2 SAMEA Image-based FFR Diagnosis Revenue by Type (2021-2032)
12.2.1 SAMEA Image-based FFR Diagnosis Revenue by Type (2021-2026)
12.2.2 SAMEA Image-based FFR Diagnosis Revenue by Type (2027-2032)
12.3 SAMEA Image-based FFR Diagnosis Revenue Share by Type (2021-2032)
12.4 SAMEA Image-based FFR Diagnosis Revenue by Application (2021-2032)
12.4.1 SAMEA Image-based FFR Diagnosis Revenue by Application (2021-2026)
12.4.2 SAMEA Image-based FFR Diagnosis Revenue by Application (2027-2032)
12.5 SAMEA Image-based FFR Diagnosis Revenue Share by Application (2021-2032)
12.6 SAMEA Image-based FFR Diagnosis Revenue by Country
12.6.1 SAMEA Image-based FFR Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Image-based FFR Diagnosis Revenue by Country (2021-2026)
12.6.3 SAMEA Image-based FFR Diagnosis Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.